Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Johansson · SciRah

Researcher profile · Semantic Scholar

L. Johansson

Share profile

L. Johansson — researcher profile on SciRah

h-index: 24
Works: 62
Citations: 3,990

Most-cited papers

Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin.
J. Bolinder, Ö. Ljunggren, J. Kullberg, L. Johansson +4 more
2012Journal of Clinical Endocrinology and Metabolism818 citations Open access
Semantic Scholar
Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin
J. Bolinder, Ö. Ljunggren, L. Johansson, John P H Wilding +4 more
2014Diabetes, obesity and metabolism487 citations Open access
Semantic Scholar
Overfeeding Polyunsaturated and Saturated Fat Causes Distinct Effects on Liver and Visceral Fat Accumulation in Humans
F. Rosqvist, D. Iggman, J. Kullberg, J. Cedernaes +7 more
2014Diabetes418 citations Open access
Semantic Scholar
Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study
J. Eriksson, P. Lundkvist, P. Jansson, L. Johansson +7 more
2018Diabetologia356 citations Open access
Semantic Scholar
Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin
Ö. Ljunggren, J. Bolinder, L. Johansson, John P H Wilding +4 more
2012Diabetes, obesity and metabolism221 citations
Semantic Scholar
The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo-Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients
A. Latva-Rasku, Miikka-Juhani Honka, J. Kullberg, N. Mononen +9 more
2019Diabetes Care212 citations
Semantic Scholar
Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non‐alcoholic fatty liver disease assessed by magnetic resonance imaging
A. Flint, G. Andersen, P. Hockings, L. Johansson +5 more
2021Alimentary Pharmacology and Therapeutics206 citations Open access
Semantic Scholar
Hydrochlorothiazide, but not Candesartan, Aggravates Insulin Resistance and Causes Visceral and Hepatic Fat Accumulation: The Mechanisms for the Diabetes Preventing Effect of Candesartan (MEDICA) Study
J. Eriksson, P. Jansson, B. Carlberg, A. Hägg +8 more
2008HYPERTENSION125 citations Open access
Semantic Scholar
Clinical and Experimental Pancreatic Islet Transplantation to Striated Muscle
G. Christoffersson, J. Henriksnäs, L. Johansson, Charlotte Rolny +7 more
2010Diabetes106 citations Open access
Semantic Scholar
Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study.
J. Oscarsson, Kristina Önnerhag, U. Risérus, M. Sundén +6 more
2018Journal of Clinical Lipidology103 citations Open access
Semantic Scholar
In Vivo Imaging of the Glucagonlike Peptide 1 Receptor in the Pancreas with 68Ga-Labeled DO3A-Exendin-4
R. Selvaraju, I. Velikyan, L. Johansson, Zhan-Hong Wu +5 more
2013Journal of Nuclear Medicine99 citations Open access
Semantic Scholar
Detection of metastatic insulinoma by positron emission tomography with [(68)ga]exendin-4-a case report.
O. Eriksson, I. Velikyan, R. Selvaraju, F. Kandeel +5 more
2014Journal of Clinical Endocrinology and Metabolism92 citations Open access
Semantic Scholar
Positron Emission Tomography Ligand [11C]5-Hydroxy-Tryptophan Can Be Used as a Surrogate Marker for the Human Endocrine Pancreas
O. Eriksson, D. Espes, R. Selvaraju, E. Jansson +11 more
2014Diabetes69 citations Open access
Semantic Scholar
Novel pancreatic beta cell-specific proteins: antibody-based proteomics for identification of new biomarker candidates.
C. Lindskog, O. Korsgren, F. Pontén, J. Eriksson +2 more
2012Journal of Proteomics66 citations
Semantic Scholar
In vivo and in vitro characterization of [18F]-FE-(+)-DTBZ as a tracer for beta-cell mass.
O. Eriksson, M. Jahan, P. Johnström, O. Korsgren +3 more
2010Nuclear Medicine and Biology61 citations
Semantic Scholar
Inhibition of fatty acid synthase with FT‐4101 safely reduces hepatic de novo lipogenesis and steatosis in obese subjects with non‐alcoholic fatty liver disease: Results from two early‐phase randomized trials
C. Beysen, P. Schroeder, E. Wu, J. Brevard +10 more
2020Diabetes, obesity and metabolism47 citations Open access
Semantic Scholar
Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population
L. Lind, L. Johansson, H. Ahlström, J. Eriksson +4 more
2020World Journal of Hepatology38 citations Open access
Semantic Scholar
Quantitative Imaging of Serotonergic Biosynthesis and Degradation in the Endocrine Pancreas
O. Eriksson, R. Selvaraju, L. Johansson, J. Eriksson +5 more
2014Journal of Nuclear Medicine38 citations Open access
Semantic Scholar
Decreased defluorination using the novel beta-cell imaging agent [18F]FE-DTBZ-d4 in pigs examined by PET
M. Jahan, O. Eriksson, P. Johnström, O. Korsgren +3 more
2011EJNMMI Research37 citations Open access
Semantic Scholar
Receptor occupancy of dual glucagon-like peptide 1/glucagon receptor agonist SAR425899 in individuals with type 2 diabetes
O. Eriksson, T. Haack, Y. Hijazi, L. Teichert +9 more
2020Scientific Reports36 citations Open access
Semantic Scholar
Dapagliflozin plus saxagliptin add‐on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes
L. Johansson, P. Hockings, E. Johnsson, Nalina Dronamraju +3 more
2020Diabetes, obesity and metabolism30 citations Open access
Semantic Scholar
Pre-clinical evaluation of [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 for imaging of insulinoma.
R. Selvaraju, I. Velikyan, Veronika Asplund, L. Johansson +7 more
2014Nuclear Medicine and Biology28 citations
Semantic Scholar
Variability in fasting lipid and glycogen contents in hepatic and skeletal muscle tissue in subjects with and without type 2 diabetes: a 1H and 13C MRS study
M. Stephenson, E. Leverton, E. Khoo, S. Poucher +6 more
2013NMR in Biomedicine27 citations
Semantic Scholar
Albuminuria‐lowering effect of dapagliflozin, exenatide, and their combination in patients with type 2 diabetes: A randomized cross‐over clinical study
A. B. van der Aart-van der Beek, E. Apperloo, N. Jongs, Dennis B Rouw +6 more
2023Diabetes, obesity and metabolism25 citations Open access
Semantic Scholar
[11C]5-hydroxy-tryptophan PET for Assessment of Islet Mass During Progression of Type 2 Diabetes
Lina Carlbom, D. Espes, M. Lubberink, M. Martinell +5 more
2017Diabetes23 citations Open access
Semantic Scholar
Magnetic resonance‐based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
C. Caussy, L. Johansson
2020Endocrinology, Diabetes & Metabolism22 citations Open access
Semantic Scholar
The Plasma Metabolomic Profile is Differently Associated with Liver Fat, Visceral Adipose Tissue, and Pancreatic Fat
L. Lind, S. Salihović, U. Risérus, J. Kullberg +4 more
2020Journal of Clinical Endocrinology and Metabolism20 citations Open access
Semantic Scholar
The development of a GPR44 targeting radioligand [11C]AZ12204657 for in vivo assessment of beta cell mass
M. Jahan, P. Johnström, R. Selvaraju, M. Svedberg +11 more
2018EJNMMI Research19 citations Open access
Semantic Scholar
First-in-class positron emission tomography tracer for the glucagon receptor
I. Velikyan, T. Haack, M. Bossart, A. Evers +7 more
2019EJNMMI Research18 citations Open access
Semantic Scholar
Magnetic Resonance Imaging in Clinical Trials of Diabetic Kidney Disease
Iris Friedli, S. Baid-Agrawal, R. Unwin, Arvid Morell +2 more
2023Journal of Clinical Medicine16 citations Open access
Semantic Scholar
Effects of DAPAgliflozin on CARDiac substrate uptake, myocardial efficiency, and myocardial contractile work in type 2 diabetes patients—a description of the DAPACARD study
A. Åkerblom, J. Oldgren, A. Latva-Rasku, L. Johansson +4 more
2019Upsala Journal of Medical Sciences16 citations Open access
Semantic Scholar
Glucagonlike Peptide-1 Receptor Imaging in Individuals with Type 2 Diabetes
O. Eriksson, I. Velikyan, T. Haack, M. Bossart +8 more
2021Journal of Nuclear Medicine13 citations Open access
Semantic Scholar
Delivery of a normal baby after preimplantation genetic diagnosis for non-ketotic hyperglycinaemia.
A. Hellani, A. Sammour, L. Johansson, Abdulssamad El-Sheikh
2008Reproductive Biomedicine Online13 citations Open access
Semantic Scholar
Assessment of glucagon receptor occupancy by Positron Emission Tomography in non-human primates
O. Eriksson, I. Velikyan, T. Haack, M. Bossart +10 more
2019Scientific Reports11 citations Open access
Semantic Scholar
Dapagliflozin plus Saxagliptin Add-On to Metformin Reduces Liver Fat and Adipose Tissue Volume in Patients with Type 2 Diabetes
J. Wilding, P. Hockings, E. Johnsson, Jill Maaske +2 more
2018Diabetes11 citations
Semantic Scholar
Long‐term effects of dapagliflozin plus saxagliptin versus glimepiride on a background of metformin in patients with type 2 diabetes: Results of a 104‐week extension to a 52‐week randomized, phase 3 study and liver fat MRI substudy
J. Frias, Jill Maaske, L. Suchower, L. Johansson +3 more
2021Diabetes, obesity and metabolism8 citations Open access
Semantic Scholar
Imaging of the Glucagon Receptor in Subjects with Type 2 Diabetes
O. Eriksson, I. Velikyan, T. Haack, M. Bossart +8 more
2020Journal of Nuclear Medicine8 citations Open access
Semantic Scholar
The Effects of Exendin-4 Treatment on Graft Failure: An Animal Study Using a Novel Re-Vascularized Minimal Human Islet Transplant Model
Afaf Sahraoui, M. S. Winzell, T. Gorman, Dave M. Smith +7 more
2015PLoS ONE8 citations Open access
Semantic Scholar
Drug Occupancy Assessment at the Glucose-Dependent Insulinotropic Polypeptide Receptor by Positron Emission Tomography
O. Eriksson, I. Velikyan, T. Haack, M. Bossart +8 more
2021Diabetes7 citations Open access
Semantic Scholar
Synthesis and biological evaluation of [11C]AZ12504948; a novel tracer for imaging of glucokinase in pancreas and liver
M. Jahan, P. Johnström, S. Nag, A. Takano +4 more
20157 citations
Semantic Scholar
Imaging of the Glucose-Dependent Insulinotropic Polypeptide Receptor Using a Novel Radiolabeled Peptide Rationally Designed Based on Endogenous GIP and Synthetic Exendin-4 Sequences
I. Velikyan, M. Bossart, T. Haack, I. Laitinen +5 more
2022Pharmaceuticals5 citations Open access
Semantic Scholar
354-OR: Cotadutide (medi0382), a Dual Receptor Agonist with Glucagon-Like Peptide-1 and Glucagon Activity, Modulates Hepatic Glycogen and Fat Content
D. Robertson, L. Hansen, P. Ambery, Russell L. Esterline +7 more
20205 citations
Semantic Scholar
Automated GMP-Compliant Production of [68Ga]Ga-DO3A-Tuna-2 for PET Microdosing Studies of the Glucagon Receptor in Humans
Michael Wagner, Johan G Doverfjord, J. Tillner, G. Antoni +7 more
2020Pharmaceuticals5 citations Open access
Semantic Scholar
MEDI0382, a GLP/Glucagon Receptor Dual Agonist, Significantly Reduces Hepatic Fat Content in Subjects with Type 2 Diabetes Mellitus
Meenakshi Jain, L. Tsai, D. Robertson, B. Hirshberg +3 more
2018Diabetes5 citations
Semantic Scholar
Membrane Protein Profiling of Human Islets of Langerhans Using Several Extraction Methods
S. Hansson, Å. Henriksson, L. Johansson, O. Korsgren +3 more
2010Clinical Proteomics5 citations Open access
Semantic Scholar
Strategy to develop a MAO-A-resistant 5-hydroxy-l-[β-11C]tryptophan isotopologue based on deuterium kinetic isotope effects
Jonas Eriksson, O. Åberg, R. Selvaraju, G. Antoni +2 more
2014EJNMMI Research3 citations Open access
Semantic Scholar
Author response for "Inhibition of fatty acid synthase with FT ‐4101 safely reduces hepatic de novo lipogenesis and steatosis in obese subjects with NAFLD non‐alcoholic fatty liver disease: results from two early phase randomized trials"
C. Beysen, P. Schroeder, E. Wu, J. Brevard +10 more
20202 citations Open access
Semantic Scholar
Decreased defluorination using the novel beta- cell imaging agent ( 18 F)FE-DTBZ-d4 in pigs
O. Eriksson, P. Johnström, O. Korsgren, A. Sundin +2 more
20112 citations
Semantic Scholar
Molecular Imaging of Diabetes
L. Joosten, M. Boss, T. Jansen, M. Brom +6 more
2021Molecular Imaging1 citations Open access
Semantic Scholar
Title : The Positron Emission Tomography ligand [ 11 C ] 5-Hydroxy-Tryptophan can be used as a surrogate marker for the human endocrine pancreas
O. Eriksson, D. Espes, R. Selvaraju, E. Jansson +11 more
20141 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

O. Eriksson×22
Invite
O. Eriksson — researcher profile on SciRah
O. Korsgren×15
Invite
O. Korsgren — researcher profile on SciRah
I. Velikyan×11
Invite
I. Velikyan — researcher profile on SciRah
J. Eriksson×10
Invite
J. Eriksson — researcher profile on SciRah

×10

Invite

G. Antoni — researcher profile on SciRah

H. Ahlström×8

Invite

H. Ahlström — researcher profile on SciRah

R. Selvaraju×8

Invite

R. Selvaraju — researcher profile on SciRah

Invite

T. Haack — researcher profile on SciRah

Invite

I. Laitinen — researcher profile on SciRah

Invite

S. Pierrou — researcher profile on SciRah

Michael Wagner×8

Invite

Michael Wagner — researcher profile on SciRah

Invite

M. Bossart — researcher profile on SciRah